The correlation between serum vitamin E level and cancer risk has been examined. Low serum levels of vitamin E caused the risk of cancer to increase in the stomach37, prostate37, and colorectum38. While, a high serum vitamin E level was protective for lung cancer39.
The serum vitamin E level correlated inversely to the mortality of colon cancer patients40, while it did not correlate to the mortality of stomach or large intestinal (except colon) cancer patients41.
An inverse correlation was observed between Liver cancer
The effects of vitamin E on the development of enzyme-altered foci in rat liver were investigat ed. The induction of gamma-glutamyltranspe ptidase-positive foci was inhibited in rats fed a diet containing 0.36, 0.72 and 1.5% (3.6, 7.2 and 15g/kg diet) vitamin E given for 6 weeks after initiation by 200mg DEN per kg body weight plus partial hepatectomy63. In another report, newborn rats were given 10mg DEN per kg body weight and fed a diet containing 500ppm (50mg/kg diet) vitamin E. After 3 months, the volume of glutathione S transferase-positive foci had significantly de creased, but after 11 months, the number and size of the foci were not different from those of rats without the treatment of vitamin E64. In hamsters fed a diet containing 1% (10g/kg diet) vitamin E for 40 weeks after the administration of 2,2' -dioxo-N-nitrosodipropylamine, vitamin E reduced the final frequency of glutathione S-trans ferase-positive foci18. A decrease of hepatic vitamin E caused the accumulation of lipid peroxides in hepatocytes. When rats were fed a diet which contained ethanol with the concentration of 7% (v/w), high levels of ethane, which is a measure of lipid peroxidation, were observed in hepatocytes. The concentration of ethane was reduced by the intraperitoneal injec tion of vitamin E (400mg/kg body weight)70. [4 -Chloro-6-(2,3-xylidino)2-pyrimidyl-thio] acetic acid could induce liver cancers in rats whose liver contained significantly low concentration of vita min E71. Pancreatic cancer When Syrian golden hamsters were fed a diet containing 1% vitamin E (10g/kg diet) for 40 weeks after the administration of 2,2'-dioxo-N nitrosodipropylamine, the frequency of ductal hyperplasia was reduced18. In azaserine-induced carcinogenesis in rats, the supplementation of vitamin E (600mg/kg diet) for 69 weeks after initiation did not interfere in the growth of acinal neoplasia, while simultaneous supplementation of vitamin E and selenium (2.5mg/kg diet) reduced the incidence of atypical nodule, adenoma and carcinoma72.
Mammary cancer
The effect of vitamin E and/or selenium sup plimentation on DMBA-induced mammary car cinogenesis was investigated in rats73-75. When both vitamin E (1,000mg/kg diet) and selenium (2.5mg/kg diet) were treated from 2 weeks before initiation by DMBA (10mg) throughout the exper iment, the mammary tumor incidence was reduced, although supplementation of vitamin E or selenium alone did not reduce the tumor incidences73. The concentration of vitamin E in the supplemented diet (1,090mg/kg diet) was 12.1 times higher than that in the control diet (90mg/ kg diet). The minimal amount of vitamin E which was effective to reduce about 50% of DMBA (7.5mg)-induced the mammary carcinomas was around 500mg/kg diet with the supplement of selenium (1mg/kg diet)74,75. It was speculated that the suppression of lipid peroxidation by vita min E along with the regulation of glutathione peroxidase by selenium was needed for the inhibi tion of mammary carcinogenesis.
Whereas, the effects of vitamin E on the immunomodulation, mitogen-induced blastogenesis and natural killer cytotoxicity were not conclusive75.
The treatment of vitamin E with the concen tration of 0.01% of diet (100mg/kg diet) was ineffective to inhibit the mammary tumor produc tion by DMBA76, nor the treatment of vitamin E with the concentration of 10 times higher (225 IU 100 Kcal) than that of the control diet was effective for the inhibition of N-methyl-N-nitrosourea induced rat mammary carcinogenesis77. Studies on vitamin E deficiency in N-methyl N-nitrosourea-induced mammary carcino genesis79,80, meanwhile, revealed a shortened latency and increased tumor multiplicities in rats consuming a diet deficient in both vitamin E and selenium, although no alteration in tumorigenicity was observed by the deficiency of either vitamin E or selenium alone. Cancers in other sites Rats fed a diet containing 1% butylated hydroxyanisole per kg diet for 52 weeks developed hyperplasia at the prefundic and mid regions of the forestomach81. The incidence of hyperplasia at the prefundic region was lower in rats fed a diet containing 1% butylated hydroxyanisole plus 1% vitamin E (10g/kg diet) than that in rats fed a diet containing 1% (w/w) butylated hydroxyanisole alone81. When mice were fed a vitamin E sup plemented diet (10g/kg diet) and a control diet alternately up to 41 weeks this treatment showed no correlation to the incidence of forestomach tumors induced by DMBA76. In 1,2-dimethylhy drazine-initiated carcinogenesis in mice, the administration of vitamin E either suppressed82 or enhanced83 tumorigenicity in the lower intestinal tract. The influence of dietary vitamin E deficiency to 1,2-dimethylhydrazine-induced intestinal tumors was investigted in rats84. When rats were fed a diet containing low level of vitamin E (less than 0.5mg/kg diet) for 30-34 weeks, the incidence of intestinal tumors was reduced84. When mice were fed a diet containing 5% of vitamin E (50g/kg diet) for 2 years, the incidence of lung tumor initiated by DEN was reduced from 82.0% to 48.0% but that of the forestomach tumor was not reduced17.
When rats were given a diet containing 1% vitamin E (10g/kg diet) for 40 weeks, there was no effect with regard to the induction of urinary bladder cancer initiated by N-butyl-N-(4-hydro xy-butyl) nitrosamine85, and when they were fed a diet containing 1.5% vitamin E for 31 weeks, there was no effect with regard to the induction of prostate cancer initiated by 3,2'-dimethyl-4 aminobiphenyl52.
In transplacental carcinogenesis, vitamin E was ineffective on the development of tumors in the nervous system and kidney by ethyl nitrosourea86. In this experiment, the dose of vitamin E was 600mg per kg diet, and the duration of feeding was 18 monthts.
Possible mechanisms
Vitamin E could inhibit some forms of chemi cally induced carcinogenesis through its ability to alter the enzymatic activities of target cells, as noted in the skin53,-55.
Injections of vitamin E immediately after the irradiation of 60Co gamma-rays (8.0 Gy) to mice enhanced the 30-day survival87. This was ex plained that the injection of vitamin E might enhance immune response or recovery of bone marrow of the host.
The antioxidative action of vitamin E could affect the inhibition of certain types of car cinogenesis. Vitamin E inhibited the formation of nitrosamines, the major suspects for stomach cancer, by reducing the oxidation of nitric dioxide, nitric oxide and nitrite contained in foods in the stomach88,89 and the formation of nitrosamines from atmospheric nitric dioxide in the skin90. Epidemiologically, the average ratios of lipid peroxide/vitamin E in the sera of cancer patients were significantly higher than those of normal controls91. Vitamin E could also reduce the level of serum lipid peroxides in tumor-bearing mice91. Consequently, the frequency to subject target cells to carcinogenic compounds was reduced. Administration of vitamin E immediately after irradiation of 60Co gamma-rays (1.0 Gy) to mice was effective to reduce the frequency of micronuclei in bone marrow cells92. This protec tive effect of vitamin E was explained by the ability of vitamin E to scavenge oxidizing free radicals. Actually, vitamin E protected liposomal mem branes from lipid peroxidation induced by an X irradiation (100 Gy)93. Vitamin E inhibited the transformation of C3H10T1/2 cells induced by X irradiation, benz(a)pyrene and tryptophan pyrolysate94. Vitamin E also inhibited the sister chromatid exchanges of Chinese hamster ovary cells induced by the liberated free radicals from phagocytes 95,96. Vitamin E protected the cells of lymphoblastoid lines and primary lymphocyte cultures from bleomycin-induced chromosomal breakage which was used as an indicator of genetic instability97. Thus, vitamin E reduced the concen tration of free radicals, protected the chromosomes from the radicals and thereby might contribute to prevent the target cells from malignant transforma tion.
Salmonella mutagenesis assay was used to study the influence of vitamin E on the mutagenic activities of carcinogens.
Vitamin E did not affect the frequency of base-substitution mutations caused by N-methyl-N'-nitro-N-nitroso guanidine98 or aflatoxin B199, nor the frequency of frameshift mutation caused by N-acetoxy-2 acetylaminofluorene98. Therefore, vitamin E does not seem to directly affect the repair of damaged DNA.
Direct carcinogenic potential of vitamin E
In acute and subchronic toxicity studies in Fischer 344 rats, oral administration of vitamin E at the dose of 2g/kg body weight daily for 13 weeks significantly reduced body weight and sur vival and alveolar hyperplasia in the lung 16. In a chronic toxicity study in CD rats, the oral adminis tration of vitamin E at the dose of 2g/kg body weight daily for 104 weeks did not exert any influence on growth rate, survival or tumor incidence100. However, vitamin E families may be a contributive carcinogen in various organs when POTENTIAL OF VITAMIN E 185 
Injection experiments
The carcinogenicity of vitamin E was demon strated by subcutaneous injection experiments. The synthetic vitamin E compound, d, I-alpha tocopheryl acetate induced soft tissue tumors, fibrosarcoma and malignant fibrous histiocytoma in one strain of rats and two strains of mice, when the agent was injected at doses of 40mg for rats and 20mg for mice subcutaneously once a week for 12 months19. A naturally occurring vitamin E, that is, a mixture of natural tocopherols, did not induce tumors by the same procedure19, although it induced soft tissue tumors when injected sub cutaneously together with vegetable oils (0.2ml for rats and 0.1ml for mice) which were not carcino genic by themselves19. Similarly, a natural alpha tocopherol at the dose of 16mg per injection in duced fibrosarcoma in a strain of mice when inject ed subcutaneously together with soya oil (0.1ml) for 10 months20. Neither the alpha-tocopherol nor the soya oil itself was effective for the induc tion of any tumors.
Possible mechanisms
It is helpful to difine vitamin E as either a tumor initiator, promoter, complate carcinogen, or progressive agent when discussing the mechanism of its carcinogenicity.
Nitta et al. reported the increase in spontaneous liver tumor frequency by the administration of vitmain E in a strain of mice genetically susceptible to liver carcinogens17. The genes affecting susceptibility to murine hepatocar cinogenesis controled the progression (tumor size) not the frequency of carcinogen-induced liver tumors101. Therefore, this effect of vitamin E could be placed under the category of tumor initia tor. 
